跳至主要内容
临床试验/NCT05488665
NCT05488665招募中不适用

The COMPLETE Treatment of Bifurcation With Two-stent Techniques: Randomized Comparison of Crush Versus Culotte Technique

Yonsei University1 个研究点 分布在 1 个国家目标入组 512 人开始时间: 2022年11月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
512
试验地点
1
主要终点
Target lesion failure

研究概览

简要总结

In this COMPLETE randomized trial, using the contemporary second-generation drug-eluting stent, we aimed to test whether the crush technique is superior to the culotte technique for the treatment of bifurcation lesions in terms of 1-year target-lesion failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥19 years
  • •De novo coronary lesions eligible for drug-eluting stent implantation
  • •Medina 1,1,1 or 1,0,1 or 0,1,1 de novo bifurcation lesions (LM or non-LM) and those of main vessel or side branch can be covered by 2 stents
  • •Reference vessel diameter of side branch ≥2.5 mm by visual estimation

排除标准

  • •Current or potential pregnancy
  • •Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator
  • •Subjects with ST elevation myocardial infarction <24 h from the onset of chest pain
  • •Cardiogenic Shock

研究组 & 干预措施

Crush technique group

Experimental

Two stenting with the Crush technique

干预措施: Crush technique (Device)

Culotte technique group

Active Comparator

Two stenting with the Culotte technique

干预措施: Culotte technique (Device)

结局指标

主要结局

Target lesion failure

时间窗: 1 year

The composite of cardiovascular death, target vessel myocardial infarction or clinically driven target lesion revascularization

次要结局

  • Target-vessel or non-target vessel myocardial infarction(1 year)
  • Clinically driven target-lesion revascularization(1 year)
  • Cardiovascular death(1 year)
  • Target vessel myocardial infarction(1 year)
  • All-cause of death(1 year)
  • Definite or probable stent thrombosis(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验